Guggenheim analyst Michael Schmidt downgrades Rubius Therapeutics (NASDAQ:RUBY) from Buy to Neutral.
Bankwell Announces New CFO; Courtney Sacchetti Has Been Appointed To Executive Vice President, Chief Financial Officer At Bankwell, Effective January 1, 2023
Courtney E. Sacchetti has been appointed to Executive Vice President, Chief Financial Officer at Bankwell, effective January 1, 2023, announced Christopher R. Gruseke, President and CEO of Bankwell and its parent
